PCVX — Vaxcyte, Inc. - Common Stock (PCVX)
Every disclosed congressional transaction in this security, both parties, every chamber. Each row links to the filing it came from.
These are legally required disclosures, not allegations — timing can be coincidence.
Who trades it, and which way
By party
Democrats 5 Republicans 3
By direction
Purchases 6 Sales 2
Inside its sector Pharmaceuticals & Biotech
Congressional transactions per security in this sector — the page you are on is highlighted.
Plus 1,063 transactions across the sector's other securities.
Follow the federal money
Why a company's stock can be sensitive to what Congress does: many of them are also paid by the government. Vaxcyte, Inc.'s federal contracts, grants and loans are public record.
Look up Vaxcyte, Inc. on USASpending →
We link to the source rather than repeat a dollar figure here. Federal awards are recorded under many recipient names — a parent company and its subsidiaries — so an accurate company-wide total has to be read at USASpending itself, where the recipient hierarchy is resolved. Present this beside the trading record and draw your own conclusions.
Transactions
| Date | Member | Action | Amount (as filed) | Owner | Filing |
|---|---|---|---|---|---|
| 2026-05-13 | Gilbert Ray Cisneros, Jr. D-CA | buy | $1,001 – $15,000 | self | record |
| 2026-05-12 | Gilbert Ray Cisneros, Jr. D-CA | buy | $1,001 – $15,000 | self | record |
| 2025-04-28 | Gilbert Ray Cisneros, Jr. D-CA | buy | $1,001 – $15,000 | self | record |
| 2025-04-15 | Gilbert Ray Cisneros, Jr. D-CA | buy | $1,001 – $15,000 | self | record |
| 2025-04-14 | Gilbert Ray Cisneros, Jr. D-CA | buy | $1,001 – $15,000 | self | record |
| 2025-03-05 | Jefferson Shreve R-IN | sell | $15,001 – $50,000 | self | record |
| 2022-12-12 | Chris Jacobs R-NY | sell | $1,001 – $15,000 | self | record |
| 2022-11-08 | Chris Jacobs R-NY | buy | $1,001 – $15,000 | self | record |
Prices are market data (split- and dividend-adjusted closes), used only for context — every disclosure fact on this page comes from the filings linked in the table above. See Methodology.